New Market Report Now Available: Cambodia Pharmaceuticals & Healthcare Report Q3 2013
We maintain that significant foreign interest in Cambodia will be unlikely given the lack of proper regulation, rampant corruption and poor infrastructure in the country. In addition, due to low per capita pharmaceutical and healthcare expenditure, the market will only be attractive to producers of low-value pharmaceutical products such as generic drugs and over-the-counter drugs from other countries, such as Vietnam.
View full press release